MedTrace Logo

The 3DKnee™ System: A Post-Market Study

NCT00764673 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2011-03-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the survivorship and efficacy of the Encore 3DKnee™ system in a group of patients who will receive the 3DKnee™ as a primary (first) orthopedic implant in the knee. Each knee will be designated as a separate subject and followed for a period of 2 years.

Conditions

Interventions

DEVICE

3DKnee

Subjects with knee osteoarthritis and willing to participate in the study

Sponsors & Collaborators

  • Encore Medical, L.P.

    lead INDUSTRY

Principal Investigators

  • John McAllister, M.D. · St. Peter's Bone and Joint Surgery

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00764673 on ClinicalTrials.gov